Last week a story broke about the renewed effort to clone the thylacine by Colossal Biosciences, based in Texas, and Andrew Pask an epigenetisist at the University of Melbourne. A week earlier I was contacted by nature and science journalist, Kate Evans, to give my opinion on the viability and ethics of such a project.
My view is one of several from science and thylacine ‘experts’ who are less optimistic about the project. Read the article here
For more responses to this latest cloning proposal see PaperTiger Facebook